Stock Market Sees Carnage Due to U.S. Monetary Policy Shift The Federal Reserve’s abandonment of easy-money policies has led to a fight to squash inflation, marking a dramatic shift in U.S. monetary policy. Investors have had to adapt to this new reality, with stock prices seeing significant drops since January 2022. Notably, major U.S. equity…
In 2023, the idea of diversifying your stock portfolio to minimize risk proved to be a disappointing strategy. A wide array of sectors such as financials, retailers, drugs, foods, utilities, autos, airlines, and oils saw steep declines if the timing of investments was not perfect. This reality challenges the classic investment rule of not putting…
Renowned stock market guru and CNBC host, Jim Cramer, weighed in on the potential value of GLP-1 drugs, commonly used to treat diabetes and obesity, as well as the companies producing them, such as Eli Lilly and Novo Nordisk. Cramer stated that these drugs could be extremely valuable with a significant impact on the pharmaceutical…
CNBC Investing Club with Jim Cramer: Key Moments from Monday’s Morning Meeting The CNBC Investing Club with Jim Cramer held its Morning Meeting livestream at 10:20 a.m. ET on Monday, discussing the latest developments in the stock market. Here are the key moments from the meeting: 1. U.S. equities experienced pressure on Monday, with the…
Eli Lilly’s stock saw a significant increase on Wednesday after the U.S. government approved the company’s GLP-1 drug for obesity treatment. The FDA’s decision was no surprise, and now Eli Lilly is gearing up to market the drug as Zepbound. The stock price soared by almost 2% in response to the news, reaching $611.36 per…
Investors Advised to Seek Safer Hideaways in Late-Cycle Market Environment, says Morgan Stanley According to a note from Morgan Stanley analyst Andrew Pauker, as economic activity reaches its peak, investors should consider defensive sectors such as health care and utilities as safer options in the market. Pauker suggests that current leading macro data and the…
